Elk Creek Partners Lowers stake in Examworks Group (EXAM)

Examworks Group (EXAM) : Elk Creek Partners reduced its stake in Examworks Group by 5.06% during the most recent quarter end. The investment management company now holds a total of 870,259 shares of Examworks Group which is valued at $30.5 Million after selling 46,394 shares in Examworks Group , the firm said in a disclosure report filed with the SEC on May 13, 2016.Examworks Group makes up approximately 2.31% of Elk Creek Partners’s portfolio.

Other Hedge Funds, Including , Citadel Advisors sold out all of its stake in EXAM during the most recent quarter. The investment firm sold 864 shares of EXAM which is valued $30,283.Timessquare Capital Management reduced its stake in EXAM by selling 4,600 shares or 0.32% in the most recent quarter. The Hedge Fund company now holds 1,450,145 shares of EXAM which is valued at $50.8 Million. Examworks Group makes up approx 0.33% of Timessquare Capital Management’s portfolio.Manufacturers Life Insurance Company The boosted its stake in EXAM in the latest quarter, The investment management firm added 233 additional shares and now holds a total of 27,432 shares of Examworks Group which is valued at $961,492. Nisa Investment Advisors L.l.c. added EXAM to its portfolio by purchasing 500 company shares during the most recent quarter which is valued at $18,025. Northpointe Capital sold out all of its stake in EXAM during the most recent quarter. The investment firm sold 7,400 shares of EXAM which is valued $266,770.

Examworks Group opened for trading at $34.81 and hit $34.88 on the upside on Wednesday, eventually ending the session at $34.8, with a gain of 0.06% or 0.02 points. The heightened volatility saw the trading volume jump to 4,32,123 shares. Company has a market cap of $1,450 M.

On the company’s financial health, Examworks Group reported $0.08 EPS for the quarter, based on the information available during the earnings call on May 10, 2016. Analyst had a consensus estimate of $0.08. The company had revenue of $226.50 million for the quarter, compared to analysts expectations of $217.47 million. The company’s revenue was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.05 EPS.

Many Wall Street Analysts have commented on Examworks Group. Examworks Group was Downgraded by Needham to ” Hold” on May 23, 2016.

ExamWorks Group Inc. (ExamWorks) provides independent medical examinations (IMEs) peer reviews bill reviews Medicare compliance case management and other related services (IME services or the IME industry). The Company has four geographic segments: the United States Canada the United Kingdom and Australia. It provides most of IME services through its medical panel of independently contracted credentialed physicians and other medical providers. Its clients include property and casualty insurance carriers law firms third-party claim administrators and government agencies that use independent services to confirm the veracity of claims by sick or injured individuals and to facilitate the delivery and quality of cost-effective care for workers’ compensation automotive personal injury liability and disability insurance coverage. The Company helps its clients manage costs and enhance their risk management and compliance processes.

Leave a Reply

Examworks Group - Is it time to Sell?

Top Brokerage Firms are advising their investors on Examworks Group. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.